Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

UCLA, Takeda to study how disruption of circadian rhythms promotes type 2 diabetes

Millions of individuals worldwide are exposed to shift work and numerous environmental conditions that disturb circadian clock function and disrupt normal circadian rhythms. Environmental conditions associated with disrupted circadian rhythms greatly increase the risk for development of type 2 diabetes and metabolic syndrome and also hinder the treatment and management of hyperglycemia in existing patients with diabetes.

13 Oct 2013

Scientists develop new method to create stem cells for human liver and pancreas

A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.

11 Oct 2013

New less invasive surgical method paves way for development of efficient anti-obesity therapies

Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures.

11 Oct 2013

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

The National University of Singapore (NUS) and A*STAR will be jointly establishing the S$148 million Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development (SiNMeD).

11 Oct 2013

Researchers find no serious adverse effects of HPV vaccine in girls

Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers.

10 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

Research suggests almonds may be good snack option for those concerned about weight

A new study published in the October issue of the European Journal of Clinical Nutrition found that study participants eating 1.5 ounces of dry-roasted, lightly salted almonds every day experienced reduced hunger and improved dietary vitamin E and monounsaturated ("good") fat intake without increasing body weight.

9 Oct 2013

Salk scientist receives Career Development Award for new research from JDRF

The Juvenile Diabetes Research Foundation has given Salk scientist Mark Huising a five-year, $750,000 Career Development Award for his proposed study on how a novel network of receptors in human islets receives and integrates molecular signals. In pre-clinical models, activation of these receptors has proven to actually prevent diabetes.

9 Oct 2013

Retirement a sticking point for antihypertensive adherence

Patients’ adherence to their antihypertensive medication may decline when they retire from work, a study shows.

8 Oct 2013

Diabetic retinopathy incidence in upward trend

Retinal damage is one of the most common complications of diabetes, affecting about 90 percent of type 1 diabetics and 75 percent of type 2 diabetics. According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.

8 Oct 2013

Study aims for new national standard on how doctors and pharmacies write prescriptions

Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.

8 Oct 2013

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.

7 Oct 2013

RowanSOM researcher receives $1.8M grant to find role of diet in preterm delivery in minority women

A researcher at the Rowan University School of Osteopathic Medicine (RowanSOM) has received a $1.8 million federal grant to determine the role diet plays in the higher incidence of preterm delivery among African American and Hispanic women.

4 Oct 2013

Prevention of type-2 diabetes prevention through diet, exercise and lifestyle

The number of diabetics worldwide is exploding. In response, the largest study of its kind to date is set to investigate type-2 diabetes prevention through diet, exercise and lifestyle. Eight EU nations, along with New Zealand, Australia and Canada, will participate in an EU-funded project headed by University of Copenhagen researchers.

3 Oct 2013

New insights into how obesity, type 2 diabetes can create stress response in the brain

Joslin researchers have gained new insights into how obesity and type 2 diabetes can create a stress response in the brain, especially in the hypothalamus (the brain region that regulates appetite and energy production), that may contribute to altering metabolism throughout the body. The findings are reported in the October issue of the Journal of Clinical Investigation.

2 Oct 2013

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

A team led by scientists at The Scripps Research Institute has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin. The finding makes possible a deeper scientific understanding of the insulin secretion process—and how it fails in insulin disorders such as type 2 diabetes.

1 Oct 2013

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin.

1 Oct 2013

Study provides new insights into type 1 diabetes pathology

Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears online today and will also appear in the January issue of Diabetes.

29 Sep 2013

JDRF applauds FDA approval of Medtronic's MiniMed 530G with Enlite system for T1D

JDRF, the leading global organization funding type 1 diabetes research, today applauded the U.S. Food and Drug Administration for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels fall below a predetermined threshold.

From Medtronic 29 Sep 2013

Joslin gets NIH grant to study potential treatment for kidney disease in people with diabetes

The National Institutes of Health awarded Joslin Diabetes Center $24.3 million to fund a clinical trial to study a potential treatment for kidney disease in people with type 1 diabetes.

27 Sep 2013

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

UCLA, Takeda to study how disruption of circadian rhythms promotes type 2 diabetes

Scientists develop new method to create stem cells for human liver and pancreas

New less invasive surgical method paves way for development of efficient anti-obesity therapies

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

Researchers find no serious adverse effects of HPV vaccine in girls

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Research suggests almonds may be good snack option for those concerned about weight

Salk scientist receives Career Development Award for new research from JDRF

Retirement a sticking point for antihypertensive adherence

Diabetic retinopathy incidence in upward trend

Study aims for new national standard on how doctors and pharmacies write prescriptions

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

RowanSOM researcher receives $1.8M grant to find role of diet in preterm delivery in minority women

Prevention of type-2 diabetes prevention through diet, exercise and lifestyle

New insights into how obesity, type 2 diabetes can create stress response in the brain

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

Study provides new insights into type 1 diabetes pathology

JDRF applauds FDA approval of Medtronic's MiniMed 530G with Enlite system for T1D

Joslin gets NIH grant to study potential treatment for kidney disease in people with diabetes

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in